Your browser doesn't support javascript.
loading
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Gregory, Timothy A; Mastall, Maximilian; Lin, Heather; Hess, Kenneth R; Yuan, Ying; Martin-Bejarano Garcia, Manuela; Fuller, Gregory N; Alfaro, Kristin D; Gule-Monroe, Maria K; Huse, Jason T; Khatua, Soumen; Rao, Ganesh; Sandberg, David I; Wefel, Jeffrey S; Yeboa, Debra N; Paulino, Arnold C; McGovern, Susan L; Zaky, Wafik; Mahajan, Anita; Suki, Dima; Weathers, Shiao-Pei; Harrison, Rebecca A; de Groot, John F; Puduvalli, Vinay K; Penas-Prado, Marta; Majd, Nazanin K.
Afiliación
  • Gregory TA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mastall M; Department of Neurology, Clinical Neuroscience and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.
  • Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hess KR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Martin-Bejarano Garcia M; Health Research Institute, Hospital Clinico San Carlos, Madrid, Spain.
  • Fuller GN; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Alfaro KD; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gule-Monroe MK; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khatua S; Department of Pediatric Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Sandberg DI; Department of Pediatric Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wefel JS; Department of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yeboa DN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Paulino AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McGovern SL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zaky W; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mahajan A; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Suki D; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Harrison RA; Department of Neuro-Oncology, BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada.
  • de Groot JF; Brain Tumor Center, UCSF Medical Center, San Francisco, California, USA.
  • Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Neurooncol Adv ; 5(1): vdad032, 2023.
Article en En | MEDLINE | ID: mdl-37114244
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos